Stay updated on Factor IX Gene Therapy in Severe Hemophilia B Clinical Trial
Sign up to get notified when there's something new on the Factor IX Gene Therapy in Severe Hemophilia B Clinical Trial page.

Latest updates to the Factor IX Gene Therapy in Severe Hemophilia B Clinical Trial page
- ChecktodayChange DetectedThe site footer revision changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA general NIH banner announces a terminology change from “Artificial Intelligence” to “Super Intelligence,” and the site revision advances from v3.7.1 to v3.7.2.SummaryDifference1%

- Check28 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page now renders a 403 Forbidden error with a minimal header, replacing the previous study record content and related navigation. This indicates the study page is currently inaccessible and shows only the error layout.SummaryDifference19%

- Check49 days agoChange DetectedThe page revision was updated from v3.6.6 to v3.7.0, indicating that an update or patch was applied to the page.SummaryDifference0.0%

- Check63 days agoChange DetectedRevision updated from v3.6.5 to v3.6.6, indicating a new build/version of the page. The change does not affect the study information or user-facing content.SummaryDifference0.0%

Stay in the know with updates to Factor IX Gene Therapy in Severe Hemophilia B Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Factor IX Gene Therapy in Severe Hemophilia B Clinical Trial page.